We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Baxalta Form 483 for Records, Building Issues and Uncorrected Observations
FDA Issues Baxalta Form 483 for Records, Building Issues and Uncorrected Observations
The FDA issued a Form 483 to Baxalta after an inspection revealed a litany of observations including two from an earlier inspection that were not corrected.